Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Since some think that CTIX has to come up with a lot of money, I wanted to add to each in your list a small detail (added wording in bold):

Planned Kevetrin trials:

1. Ovarian – single agent and in combo, phase 2, orphan status
to be heavily subsidized by government and private grants

2. Pancreatic – single agent, phase 2, orphan status and research grant applied
Unmet need cancer funding available, CTIX will supply little more than the drug.

3. AML – single agent and in combo with cytarabine, phase 2, paid for entirely by University of Bologna

4. Renal – in combo with a tyronsine kinase inhibitor, phase 2, possible Specialized Programs of Research Excellence (SPORE) grant

5. Retinoblastoma – single agent, phase 2, possible Pediatric Disease Priority Review Voucher (PPRV)
Funded by Children's Cancer Research Fund among other sources including the NIH.